AzTrials
AzTrials

Sex, UnsafeNCT03685643

Study Proposal for Web Based Intervention to Promote the Safe Usage of Dating Applications in Young Adults

A study testing Intervention - Dating application topic in people with Sex, Unsafe and Adolescent Behavior, run by The University of Hong Kong at 2 sites in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will evaluate the effectiveness of a program in promoting the safe usage of dating applications amongst young adults in Hong Kong. One group will receive the program regarding dating applications and the other group will receive a placebo program regarding health and exercise. Read more about this study

Who is it for?
Ages 17 to 27 yearsHealthy volunteers can take part
Conditions the study is for
Sex, Unsafe, Adolescent Behavior, Behavior, Sex
What is being tested?
Intervention - Dating application topic
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
578 participants
Where
2 sitesHong Kong
Study dates
7 Sep 2018to 7 Aug 2019
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 27 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • 17-27 years old
  • Able to read and understand Chinese

Who cannot join

  • Have a physical impediment (e.g. blindness) to prevent them from accessing the content

Trial locations and contacts

2 sites in 1 country.

Hong Kong2 sites
  • Caritas Institute of Community Education

    Hong Kong

  • Vocational Training Council (VTC)

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Study Protocol for a Peer-led Web-based Intervention to Promote Safe Usage of Dating Applications Amongst Young Adults: A Cluster Randomized Controlled Trial

This study will evaluate the effectiveness of a program in promoting the safe usage of dating applications amongst young adults in Hong Kong. One group will receive the program regarding dating applications and the other group will receive a placebo program regarding health and exercise.

Read the detailed description

Dating applications are a popular platform to meet new people; however, they have been associated with risks such as unsafe sexual behavior and privacy concerns in young adults.

The study design is an open-labeled cluster randomized controlled trial with an intervention and a placebo control arm. The intervention group will receive a web-based intervention developed through focus group discussions, crowdsourcing contest, and a Peer-Vetted Creative Production (PVCP) workshop comprising of four short videos, a risk assessment tool, and a scenario game. The control group will receive a web-based resource with similar multimedia elements on health and exercise.

Based on the Information, Motivation, and Behavioral Skills (IMB) Model, the primary outcome of this study is self-efficacy in using dating applications measured by the General Self Efficacy Scale. Secondary outcomes include change in attitudes regarding risk perception measured by the Risk Propensity Scale and depression symptoms.

Being tested
Intervention - Dating application topic, Control - Health and exercise topic
Keywords
Peer-led, dating applications, young adults, sexual behavior
Medical subject headings
Unsafe Sex, Adolescent Behavior, Sexual Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intervention - Dating application topicBehavioural

    The intervention will consist of multimedia content to promote the safe usage of dating applications and raise awareness of the risks associated with dating application usage. The intervention will be delivered one-time in a classroom setting.

  • Control - Health and exercise topicBehavioural

    The placebo control will consist of multimedia content regarding exercise and healthy living. It will be delivered once-time in a classroom setting.

Study groups in NCT03685643
Study groupRoleWhat they receive
Intervention - Dating application topicExperimentalThe intervention will consist of four short videos with points of discussion, a scenario game, and a risk assessment tool regarding dating application usage.
Receives: Behavioral: Intervention - Dating application topic
Control - Health and exercise topicPlacebo comparatorThe control will consist of four short videos with discussion points and an interaction game regarding exercise and healthy living tips.
Receives: Behavioral: Control - Health and exercise topic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self Efficacy: This Will be Measured by the General Self Efficacy Scale

    The primary outcome will be the self-efficacy on the safe usage of dating. applications among young adults in Hong Kong. This will be measured by the General Self Efficacy Scale. The General Self Efficacy Scale is a 10-item scale (with 4 level Likert scale ranging from "not true at all" to "exactly true") measuring one's self-belief in completing certain tasks or overcoming difficulties. The total score is calculated by finding the sum of all items with the total score ranging between 10 and 40, with a higher score indicating a higher level of self efficacy.

    Measured: 8 months

Secondary outcomes (2)
  1. Risk Taking Tendencies Will be Measured by the The Risk Propensity Scale.

    Participants' risk taking tendencies will be measured by the The Risk Propensity Scale. It is a 9-item scale measuring general risk-taking tendencies. Each item is rated on a 9 level Likert scale (ranging from "totally disagree" to "totally agree") with the final score ranging from 1-9. A higher score indicates higher risk-taking tendencies.

    Measured: 8 month

  2. Depression Symptoms Will be Measured by the Patient Health Questionnaire-2 (PHQ-2).

    Participants' risk of depression will be measured by the Patient Health Questionnaire-2 (PHQ-2). This is a 2 item scale (with a 4 level Likert scale ranging from "Not at all" to "Nearly everyday") and the score ranges from 0-6, with a higher score indicating higher risk of depression.

    Measured: 8 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2018
  2. Study start7 Sep 2018
  3. Primary completion7 Aug 2019
  4. Study completion7 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
578 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03685643
Sponsor's protocol ID
09160275
Other IDs
HKUCTR-2512
Status last verified
Apr 2020
First submitted
20 Sep 2018
Last updated
28 Apr 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will include baseline demographics, dating application usage and behavior, and the primary and secondary outcomes.

Publications

  • Wong WC, Sun WH, Chia SMC, Tucker JD, Mak WP, Song L, Choi KWY, Lau STH, Wan EYF. Effectiveness of a Peer-Led Web-Based Intervention to Improve General Self-Efficacy in Using Dating Apps Among Young Adults: Randomized Clustered Trial. J Med Internet Res. 2020 Oct 30;22(10):e16378. doi: 10.2196/16378.

    PubMed 33124987
  • Lau STH, Choi KWY, Chen J, Mak WP, Yeung HKCA, Tucker J, Wong WC. Study protocol for a peer-led web-based intervention to promote safe usage of dating applications among young adults: a cluster randomized controlled trial. Trials. 2019 Feb 6;20(1):102. doi: 10.1186/s13063-018-3167-5.

    PubMed 30728064

Questions about this trial

What is this clinical trial studying?

A study testing Intervention - Dating application topic in people with Sex, Unsafe and Adolescent Behavior, run by The University of Hong Kong at 2 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 28 Apr 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self Efficacy: This Will be Measured by the General Self Efficacy Scale (time frame: 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03685643, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in